ArticleNature medicine2025

Antisense oligonucleotide treatment in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy.

Matias Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.